← back to search

Maryam M. Asgari

Massachusetts General Hospital · US
Area of research
Oncology · Epidemiology
Research interest
Research interests include Nonmelanoma Skin Cancer Studies, Cutaneous Melanoma Detection and Management, Skin Protection and Aging, and Cutaneous lymphoproliferative disorders research.
h-index
44
citations
6,423
works
225
NIH funding
primary concept
email

Recent publications

Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy
JAMA Dermatology 2022cited by 128position: middledoi
Guidelines of care for the management of actinic keratosis
Journal of the American Academy of Dermatology 2021cited by 157position: middledoi
Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients
JAMA Dermatology 2021cited by 62position: middledoi
Vitamin D deficiency exacerbates UV/endorphin and opioid addiction
Science Advances 2021cited by 36position: middledoi
Guidelines of care for the management of actinic keratosis: Executive summary
Journal of the American Academy of Dermatology 2021cited by 24position: middledoi
Perioperative Serum 25-Hydroxyvitamin D Levels as a Predictor of Postoperative Opioid Use and Opioid Use Disorder: a Cohort Study
Journal of General Internal Medicine 2020cited by 13position: lastdoi
Targeted Genomic Profiling of Acral Melanoma
JNCI Journal of the National Cancer Institute 2019cited by 182position: lastdoi
Keratinocyte Carcinomas: Current Concepts and Future Research Priorities
Clinical Cancer Research 2019cited by 173position: middledoi
Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients
British Journal of Dermatology 2017cited by 61position: lastdoi
Prognostic factors and survival in acral lentiginous melanoma
British Journal of Dermatology 2017cited by 60position: firstdoi
Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma
Journal of Investigative Dermatology 2016cited by 93position: firstdoi
Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized HealthCare Data, 1996 to 2009: Underrecognition in a US Health Care Setting
The Permanente Journal 2016cited by 41position: middledoi
Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012
JAMA Dermatology 2015cited by 189position: firstdoi
Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients
American Journal of Transplantation 2015cited by 68position: middledoi
Effect of Host, Tumor, Diagnostic, and Treatment Variables on Outcomes in a Large Cohort With Merkel Cell Carcinoma
JAMA Dermatology 2014cited by 103position: firstdoi
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009
Pharmacoepidemiology and Drug Safety 2013cited by 112position: firstdoi
Incidence and Prevalence of Juvenile Idiopathic Arthritis Among Children in a Managed Care Population, 1996–2009
The Journal of Rheumatology 2013cited by 98position: middledoi
Initiation of <scp>TNF</scp> inhibitor therapy and change in physiologic measures in psoriasis
Journal of the European Academy of Dermatology and Venereology 2013cited by 11position: middledoi
Vitamin D in cutaneous carcinogenesis
Journal of the American Academy of Dermatology 2012cited by 70position: lastdoi
Association of Vitamin A and Carotenoid Intake with Melanoma Risk in a Large Prospective Cohort
Journal of Investigative Dermatology 2012cited by 56position: firstdoi
Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
PLoS ONE 2012cited by 19position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey R. Curtis · University of Alabama at Birmingham4 papers (2013–2016)Lisa J. Herrinton · Seattle Children's Hospital4 papers (2013–2016)Jashin J. Wu · Novartis (Switzerland)4 papers (2013–2016)Leslie R. Harrold · New York University4 papers (2013–2016) · 3 papers (2013–2016)Joel M. Gelfand · University of Pennsylvania3 papers (2013–2016)Sarah T. Arron · College of San Mateo3 papers (2015–2019)Eric Jorgenson · Regeneron (United States)3 papers (2016–2019)Esther E. Freeman · Harvard University2 papers (2021–2021) · 2 papers (2014–2017)Robert P. Dellavalle · University of Minnesota Medical Center2 papers (2021–2021) · 2 papers (2021–2021)Gary Goldenberg · New York University2 papers (2021–2021) · 2 papers (2021–2021)Todd Schlesinger · Medical University of South Carolina2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021)David J. Leffell · Palo Alto University2 papers (2021–2021)Peggy A. Wu · University of California, Davis2 papers (2021–2021)